503 related articles for article (PubMed ID: 26198880)
1. Quantitative Susceptibility Mapping: Concepts and Applications.
Reichenbach JR; Schweser F; Serres B; Deistung A
Clin Neuroradiol; 2015 Oct; 25 Suppl 2():225-30. PubMed ID: 26198880
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.
Liu C; Li W; Tong KA; Yeom KW; Kuzminski S
J Magn Reson Imaging; 2015 Jul; 42(1):23-41. PubMed ID: 25270052
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility-weighted imaging: current status and future directions.
Liu S; Buch S; Chen Y; Choi HS; Dai Y; Habib C; Hu J; Jung JY; Luo Y; Utriainen D; Wang M; Wu D; Xia S; Haacke EM
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27192086
[TBL] [Abstract][Full Text] [Related]
4. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
Betts MJ; Acosta-Cabronero J; Cardenas-Blanco A; Nestor PJ; Düzel E
Neuroimage; 2016 Sep; 138():43-63. PubMed ID: 27181761
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Susceptibility Mapping (QSM) Algorithms: Mathematical Rationale and Computational Implementations.
Kee Y; Liu Z; Zhou L; Dimov A; Cho J; de Rochefort L; Seo JK; Wang Y
IEEE Trans Biomed Eng; 2017 Nov; 64(11):2531-2545. PubMed ID: 28885147
[TBL] [Abstract][Full Text] [Related]
6. An interleaved sequence for simultaneous magnetic resonance angiography (MRA), susceptibility weighted imaging (SWI) and quantitative susceptibility mapping (QSM).
Chen Y; Liu S; Buch S; Hu J; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Apr; 47():1-6. PubMed ID: 29154893
[TBL] [Abstract][Full Text] [Related]
7. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM).
Schweser F; Deistung A; Reichenbach JR
Z Med Phys; 2016 Mar; 26(1):6-34. PubMed ID: 26702760
[TBL] [Abstract][Full Text] [Related]
8. Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase.
Hsieh MC; Kuo LW; Huang YA; Chen JH
Magn Reson Med; 2017 Feb; 77(2):592-602. PubMed ID: 26834053
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility map-weighted imaging (SMWI) for neuroimaging.
Gho SM; Liu C; Li W; Jang U; Kim EY; Hwang D; Kim DH
Magn Reson Med; 2014 Aug; 72(2):337-46. PubMed ID: 24006248
[TBL] [Abstract][Full Text] [Related]
10. [Principles and applications of susceptibility weighted imaging].
Kurz FT; Freitag M; Schlemmer HP; Bendszus M; Ziener CH
Radiologe; 2016 Feb; 56(2):124-36. PubMed ID: 26842998
[TBL] [Abstract][Full Text] [Related]
11. Overview of quantitative susceptibility mapping.
Deistung A; Schweser F; Reichenbach JR
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27434134
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1.
Haacke EM; Mittal S; Wu Z; Neelavalli J; Cheng YC
AJNR Am J Neuroradiol; 2009 Jan; 30(1):19-30. PubMed ID: 19039041
[TBL] [Abstract][Full Text] [Related]
13. 2D harmonic filtering of MR phase images in multicenter clinical setting: toward a magnetic signature of cerebral microbleeds.
Kaaouana T; de Rochefort L; Samaille T; Thiery N; Dufouil C; Delmaire C; Dormont D; Chupin M
Neuroimage; 2015 Jan; 104():287-300. PubMed ID: 25149849
[TBL] [Abstract][Full Text] [Related]
14. Quantitative susceptibility mapping: current status and future directions.
Haacke EM; Liu S; Buch S; Zheng W; Wu D; Ye Y
Magn Reson Imaging; 2015 Jan; 33(1):1-25. PubMed ID: 25267705
[TBL] [Abstract][Full Text] [Related]
15. Improved T2* imaging without increase in scan time: SWI processing of 2D gradient echo.
Soman S; Holdsworth SJ; Barnes PD; Rosenberg J; Andre JB; Bammer R; Yeom KW
AJNR Am J Neuroradiol; 2013; 34(11):2092-7. PubMed ID: 23744690
[TBL] [Abstract][Full Text] [Related]
16. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.
Wang Y; Spincemaille P; Liu Z; Dimov A; Deh K; Li J; Zhang Y; Yao Y; Gillen KM; Wilman AH; Gupta A; Tsiouris AJ; Kovanlikaya I; Chiang GC; Weinsaft JW; Tanenbaum L; Chen W; Zhu W; Chang S; Lou M; Kopell BH; Kaplitt MG; Devos D; Hirai T; Huang X; Korogi Y; Shtilbans A; Jahng GH; Pelletier D; Gauthier SA; Pitt D; Bush AI; Brittenham GM; Prince MR
J Magn Reson Imaging; 2017 Oct; 46(4):951-971. PubMed ID: 28295954
[TBL] [Abstract][Full Text] [Related]
17. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2*-imaging at ultra-high magnetic field strength.
Deistung A; Schäfer A; Schweser F; Biedermann U; Turner R; Reichenbach JR
Neuroimage; 2013 Jan; 65():299-314. PubMed ID: 23036448
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in susceptibility-weighted imaging of the pediatric brain.
Bosemani T; Verschuuren SI; Poretti A; Huisman TA
J Neuroimaging; 2014; 24(3):221-5. PubMed ID: 24015797
[TBL] [Abstract][Full Text] [Related]
19. Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology.
Fushimi Y; Nakajima S; Sakata A; Okuchi S; Otani S; Nakamoto Y
J Magn Reson Imaging; 2024 Jun; 59(6):1914-1929. PubMed ID: 37681441
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional quantitative susceptibility mapping from standard fMRI studies.
Sun H; Seres P; Wilman AH
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27687150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
